Tech Company Financing Transactions
Linnaeus Therapeutics Funding Round
Small Business Innovation Research (SBIR) participated in a $2 million funding round for Linnaeus Therapeutics. The round was announced by the company on 3/26/2025.
Transaction Overview
Company Name
Announced On
3/26/2025
Transaction Type
Debt
Amount
$2,000,000
Round
Undisclosed
Proceeds Purpose
The award will help fund the clinical development of its lead compound, LNS8801, which targets a G protein-coupled receptor (GPER), for the treatment of metastatic cutaneous melanoma as a monotherapy in patients who cannot tolerate immunotherapy.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
30 Washington Ave. F
Haddonfield, NJ 08033
USA
Haddonfield, NJ 08033
USA
Phone
Website
Email Address
Overview
Linnaeus Therapeutics is a development stage biotech company engaged in the identification and development of small molecule agents for the treatment of cancer. Linnaeus is a Penn Center for Innovation UPstart company that was founded in 2016. Linnaeus is based upon discoveries from the Ridky lab at the University of Pennsylvania.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Patrick Mooney
Co-Founder
Todd Ridky
VP - R & D
Tina Garyantes
VP - R & D
Christopher Natale
Browse more venture capital transactions:
Prev: 3/26/2025: Nabhdrishti Aerospace venture capital transaction
Next: 3/26/2025: Uresta venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record tech company VC transactions. All VC database entries on this site are derived from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs